During the development of Qualia Joint Health, we put our newest health product to the test to find out how users would respond. Here are the results.
During the development of Qualia Energy Shot®, we put it to the test to find out how users would respond. Here’s what we did, and how participants responded.
Explore the results of our second placebo-controlled clinical study for Qualia NAD+®.
A double-blind, placebo-controlled clinical trial of Qualia Senolytic showed a statistically significant reduction in total scores of issues related to joint health and performance, which includes Joint Discomfort, Physical Function, and Joint Stiffness.
Read the exciting results of our double-blind, placebo-controlled clinical trial of Qualia NAD+.
During the development of the new and improved Qualia Mind® we put the new version of the product to the test to find out how users would respond. Here are the results.
During the development of Qualia Probiotic+ we put our newest product to the test to find out how users would respond. Here’s what we did, and how participants responded.
During the development of Qualia Senolytic, Qualia put our newest healthy aging product to the test to find out how users would respond.
We share the results of our Qualia Magnesium+ beta study. Learn more!
A new study provides hope as cognitive decline improved after six months of personalized lifestyle interventions, including Qualia Mind.
In September-October 2018, a 3-week sample of Qualia Mitochondria+ (formerly called Qualia Life) was sent to volunteers. Volunteers were selected to include a mix of people who were and were not currently taking Qualia Mind. No information was given on what product was intended to do, ingredients contained in the product, or expected responses. Instructions were to take 8 capsules with breakfast 5 days a week, with 2 off days, for 3 weeks. All participants were asked to complete a survey questionnaire after 5 days, 2 weeks, and 3 weeks. Seventy-one persons completed the 3 weeks of supplementation and provided responses to the survey.
Qualia Focus was formulated as a nootropic to support mental energy. When the brain has more resources that support mental energy, the demanding cognitive functions we need to do during the day—tasks that take mental effort—feel easier.
The 36-Item Short Form Survey Instrument (SF-36) was developed at RAND as part of the Medical Outcomes Study. It is one of the most widely used tools to assess health status and health-related quality of life.
A small pilot study of Qualia Mitochondria+—originally branded as Qualia Life—was conducted during the winter months of 2019-20. Functional testing was done using the AgeMeter® device and software.
During the development of Qualia NAD+ we put our newest product to the test to find out how users would respond. Here’s what we did, and how participants responded.
A small pilot study of Qualia Mitochondria+—originally branded as Qualia Life—was conducted on 9 individuals in November-December 2019 as part of a larger research project by Longevity Diagnostics Research.
